Table 3.
TAVI indication.
| Overall study population (n = 129) | |
|---|---|
| Prior CABG | 36 (27.9) |
| Porcelain Aorta | 31 (24) |
| Severe LV systolic dysfunction | 28 (21.7) |
| Prior chest radiation | 25 (19.4) |
| Severe lung disease | 11 (8.5) |
| Hemodynamic instability | 9 (7.0) |
| Advanced liver disease | 6 (4.6) |
| Active cancer | 5 (3.9) |
| > 1 risk factor for cardiac surgery | 27 (21) |
CABG: coronary artery bypass graft. LV: left ventricle.